Results 241 to 250 of about 47,856 (273)
Clinical characteristics and outcomes in patients with <i>Anti</i>-MDA5 positive interstitial lung disease: A case series from a lung transplant center. [PDF]
Respir Med Case RepHage R +3 more
europepmc +1 more source
Diffuse erythema with "angel wings" sign in Belgian patients with antismall ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis. [PDF]
JAAD Case RepDens AC +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dermatomyositis und juvenile Dermatomyositis
Zeitschrift für Rheumatologie, 2022Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already occur in children but first onset can also be in older adulthood. Myalgia and muscle weakness can occur later in the course of the disease or even be completely absent in some forms.
Frank, Dressler, Britta, Maurer
openaire +2 more sources
Zeitschrift für Rheumatologie, 2009
Dermatomyositis (DM) is a systemic inflammatory disease involving skin, muscles and other organs. Immunologically mediated inflammation of small vessels leads to vascular damage, especially of the muscular tissue. Typically DM presents clinically with DM-type local or generalized rash and proximal muscular weakness. Laboratory signs of muscular damage (
E. Genth, G. Stoltenburg-Didinger
openaire +4 more sources
Dermatomyositis (DM) is a systemic inflammatory disease involving skin, muscles and other organs. Immunologically mediated inflammation of small vessels leads to vascular damage, especially of the muscular tissue. Typically DM presents clinically with DM-type local or generalized rash and proximal muscular weakness. Laboratory signs of muscular damage (
E. Genth, G. Stoltenburg-Didinger
openaire +4 more sources